摘要
目的:为临床正确应用脂肪乳氨基酸(17)葡萄糖(11%)注射液(1400 mL)及相关药品提供参考。方法:对2022年1月~2022年6月住院患者443例计452份应用脂肪乳氨基酸(17)葡萄糖(11%)注射液(1400 mL)的长期医嘱及相关用药进行点评分析。结果:452份住院长期医嘱中,胃肠外科212份(46.90%);平均年龄(66.83±11.49)岁;≥61岁者326例(73.59%);危重症、中重度烧伤、围手术期和肿瘤患者未添加多种微量元素制剂421份(93.14%),添加维生素C注射液178份(39.38%),用药期间未监测肝肾功能109份(24.12%)。结论:脂肪乳氨基酸(17)葡萄糖(11%)注射液(1400 mL)存在肝肾功能异常患者不适宜使用、缺少维生素和微量元素的营养素配比不能满足患者个体化要求等问题。临床药师应对该制剂的临床应用及相关用药医嘱进行适宜性审核,规范其合理使用。
Objective:To provide reference for the correct application of fat emulsion,amino acids(17)and glucose(11%)injections(1400 mL)and related drugs.Methods:A total of 452 long-term doctor's advices(LDA)of 443 inpatients from January 2022 to June 2022 treated with fat emulsion,amino acid(17)and glucose(11%)injections(1400 mL)were reviewed and analyzed.Results:Among the 452 LDA for fat emulsion,amino acid(17)and glucose(11%)injections(1400 mL),212(46.90%)were from gastrointestinal surgery,421(93.14%)for critically ill,moderate to severe burn,perioperative,or tumor patients were not supplemented with multi trace elements,178(39.38%)were mixed with vitamin C injections,and 109(24.12%)were not monitored for liver and kidney function during the treatment.The average age of the 443 patients included was(66.83±11.49)years,and 326(73.59%)were over 61 years.Conclusion:There are still some problems in the use of fat emulsion,amino acid(17)and glucose(11%)injections(1400 mL)such as inappropriate use for patients with liver and kidney dysfunction,lack of vitamins and unsuitable trace elements for patients'individualized requirements.Clinical pharmacists should review the suitability of LDA and related medical advice to standardize their rational use.
作者
戴曼
秦守权
杜宇
梁茂本
DAI Man;QIN Shouquan;DU Yu;LIANG Maoben(Department of Pharmacy,Huai'an First Hospital Affiliated to Nanjing Medical University,Huai'an 223300,China)
出处
《药学与临床研究》
2023年第3期254-257,共4页
Pharmaceutical and Clinical Research
基金
江苏省药学会—奥赛康医院药学科研基金(A202238)。
作者简介
戴曼,女,主管药师,E-mail:154593322@qq.com;通信作者:梁茂本,男,主任药师,E-mail:liangmaoben@sina.com。
